This script search US Code. View Rule
Menu Item - Home
Menu Item - Agenda Main page
Menu Item - Historical Agenda
Menu Item - Historical Agenda
Menu Item - Agenda Search
Menu Item - EO Dashboard
Menu Item - Reg Review
Menu Item - EO Agency lists
Menu Item - EO Search
Menu Item - EO Historical Reports
Menu Item - Review Counts
Menu Item - OIRA Letters
Menu Item - EOM 12866 Search
Menu Item - EO XML Reports
Menu Item - ICR Dashboard page
Menu Item - ICR Main page
Menu Item - ICR Search
Menu Item - ICR XML Reports
Menu Item - FAQ
Menu Item - Additional Resources
Menu Item - Contact Us
Search: Agenda Reg Review ICR
       Search

View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

HHS/FDA RIN: 0910-AC45 Publication ID: Fall 2002 
Title: Regulation of Carcinogenic Compounds Used in Food-Producing Animals; Definition of "No Residue" 
Abstract: The Food and Drug Administration (FDA) is amending its regulations relating to the operational definition of the term "no residue." The definition is used in determining whether any residue of carcinogenic compounds used in food-producing animals would "be found in the food produced from those animals under conditions of use reasonably certain to be followed in practice" (21 CFR 500.80(a)). Under the current operational definition of no residue, it is possible for a residue detected by a method approved by FDA to be considered "no residue." FDA is revising its regulations to make them consistent with a 1995 Department of Justice opinion regarding this definition. The changes revise the definition of "no residue" to mean that no residue is detected with an approved regulatory method. The rule has several conditions that sponsors of carcinogenic compounds must satisfy with respect to the sponsors' proposed regulatory methods. 
Agency: Department of Health and Human Services(HHS)  Priority: Substantive, Nonsignificant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 500.82; 21 CFR 500.84; 21 CFR 500.88 
Legal Authority: 21 USC 321; 21 USC 331; 21 USC 342; 21 USC 343; 21 USC 348; 21 USC 351 to 353; 21 USC 360b; 21 USC 371 
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  01/17/2002  67 FR 2384 
NPRM Comment Period Ends  04/17/2002   
Final Action  01/00/2003   
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
Related RINs: Previously reported as 0910-AC13 
Agency Contact:
Steven Brynes
Regulatory Scientist
Department of Health and Human Services
Food and Drug Administration
HFV-151, Center for Veterinary Medicine, 7500 Standish Place,
Rockville, MD 20855
Phone:301 827-6975
Email: sbrynes@cvm.fda.gov

 
About Us   Vertical Spacer Spacer Related Resources   Vertical Spacer Spacer Disclosure   Vertical Spacer Spacer Accessibility   Vertical Spacer Spacer Privacy Policy   Vertical Spacer Spacer Contact Us